11th Annual European PRO & eCOA Congress to Gather Innovators in Advancing Patient-Centric Clinical Research to Improve Quality of Life

Premier eClinical outcomes event hosted by PHT Corporation, leading provider of electronic clinical outcome assessment (eCOA) systems used in 800+ trials

BOSTON & GENEVA--()--Clinical research KOLs will convene at the 11th Annual European PRO and eCOA Congress 22-24 September 2015 in Lisbon, Portugal. Attendees gain expertise in the science, technologies, and regulatory requirements of patient reported outcomes (PROs) and electronic clinical outcome assessments (eCOAs). The Congress is hosted by PHT Corporation and event sponsors Bluebird, Inc. and eyeforpharma.com.

Click here to learn more and register.

The program gives participants a 360 degree view on how all stakeholder groups can work with PRO and eCOA data and lead actionable eCOA initiatives at their organizations. Leading agenda items around eCOA include the BYOD debate, risk-based monitoring, regulatory updates and best practices for implementing a patient-driven eData system.

Lisbeth Bregnhøj, Medicines Inspector, Danish Health and Medicines Authority will present the Keynote Address, “Comparisons of Regulatory Perspectives and Guidance on eSource.”

Confirmed speakers also include:

  • Dr. Michael Binder, Director of Operations, Scope International AG, “Risk-Based Monitoring & eClinical Systems”
  • Vivienne van de Walle MD, PhD, CPI, Medical Director, PT&R, “Experiences in Risk-Based Monitoring and eCOA” (Click here to read Dr. van de Walle’s article “The Site Experience: Using Technology to Advance Clinical Research”)
  • Eva Ticinelli, Clinical Research Manager LETI Pharma GmbH, “Practical Experiences with BYOD in a Phase III Trial”
  • Bryan McDowell, Global Program Team Director, Novartis, “Innovation in Clinical Trials and the Patient Experience”

Full PRO & eCOA Congress Agenda

Sheila Rocchio, PHT Corporation Vice President of Marketing and Corporate Strategy, explained, “The Congress is the only premier event focused on promoting the quantifiable science, business and regulatory benefits of adopting eCOA technologies for patient-focused clinical research.” Learn why clinical research professionals think the PRO & eCOA Congress is a must attend industry event: bit.ly/AnnecyPROCongress

The Congress is designed for research professionals in Clinical Operations; Data Management; Regulatory Affairs; Outsourcing; eClinical Technologies; and, Health Outcomes. Learn more.

About PHT Corporation

PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedInFacebookTwitterGoogle+ and YouTube.

Contacts

For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com

Release Summary

Clinical research KOLs will convene at the 11th Annual European PRO & eCOA Congress 22-24 September 2015 in Lisbon, Portugal, hosted by patient-driven eData systems innovator PHT Corporation

Contacts

For PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com